BIOTECH FRANCE |
|
| Quick Click ! | Monthly news | Home-Site | Contactexpress | Faqs | Legends | Search | Companies | Events | Environment | Memories | Home-Biotech |
|---|
Abcys |
AB Science |
Adocia |
Advicenne Pharma |
Affichem |
Agate Bioservices |
Aisa Therapeutics |
Alfact Innovation |
AliX |
Alizé Pharma |
Alphelys |
Ambiotis |
Anaconda Pharma |
Aptys Pharmaceuticals |
Ariana Pharmaceuticals |
Atlantic Bone Screen |
Aureus Pharma |
B Cell Design |
BioAlliance Pharma |
Biocortech |
BioCydex |
BioMedical Diagnostics |
Biométhodes |
Biom'up |
BioProtein Technologies |
BioQuanta |
BioSystems International |
BMSystems (Bio-modeling) |
BT Pharma |
Carmat |
Cellectis |
Cellial Technologies |
CellVax |
CellVir |
Cerenis Therapeutics |
Cezanne |
CliniGenetics |
Covalab |
Cytheris |
Cytomics |
Cytoo |
DBV Technologies |
DNA Therapeutics |
Domain Therapeutics |
Dynabio |
EchoSens |
Edelris |
Endotis Pharma |
Epixis |
ERYtech Pharma |
Exonhit |
Eye Tech Care |
Flamel Technologies |
Fluofarma |
GemacBio |
Genepep |
Genewave |
Genfit |
GenOdyssee |
Genomic Vision |
GenoSafe |
GenoScience Pharma |
Genoscreen |
GenOway |
GTP Technology |
Helios Biosciences |
Hybrigenics |
Hyphen BioMed |
Imagene |
ImmunId |
Immutep |
Imstar |
In-Cell-Art |
Indicia Biotechnology |
InGen Biosciences (AbAg) |
Innate Pharma |
InnaVirVax |
Innovative Health Diagnostics |
IntegraGen |
Ipsogen |
I-Stem |
Karcinolys |
Keosys |
LibraGen |
Magnisense |
Mapreg |
MAT Biopharma |
Mauna Kea Technologies |
Medesis Pharma |
Mellitech |
Metabolys |
MicroBioChips |
MilleGen |
MitoProd |
Murigenetics |
Mutabilis |
Myosix |
NanoBiotix |
Neorphys |
Neovacs |
Netris-Pharma |
Neuronax |
NicOx |
Nokad |
Nosopharm |
Nova Decision |
Novagali |
NovoCIB |
Novotec |
Obe Therapy |
Oligovax |
Oncodesign |
Oroxcell |
Oxincell |
Palumed |
PharmaLeads |
Pharmaxon |
Pharnext |
PhenoPro |
Pherecydes Pharma |
PolyIntell |
PraXcell |
Proteogenix |
Protéus |
Protexel |
PX’Therapeutics |
Quantum Genomics |
Rhenovia Pharma |
ScarCell Therapeutics |
Sepal Pharma |
Serial Genetics |
Sisène Biotechnologies |
Skuld-Tech |
Synapcell |
Synprosis |
Tc Land Expression |
Theraclion |
TheraVectys |
Transgene |
Trophos |
TxCell |
UroGene |
UROsphere |
Urrma |
Vaxon Biotech |
Vectalys |
VigiCell |
Vivalis |
XenTech |
Zeta Biotech |
|
|
|
|
|
ONCE FRENCH BIOTECHS, TODAY ?... HATS-OFF TO VALOROUS TEAMS !
* APTANOMICS *2001 - Rhône-Alpes Discovery, Drugs
|
2002 - IDF
Paris
www.bionexis.com
Discovery, Drugs
Key words: Imaging radio-pharmaceuticals, Targeted drugs, Lipid-protein interaction, Apoptosis, Afim
Mission: to develop intelligent molecules for imaging and therapeutic applications, based on know-how on membrane protein-lipid interactions, focused on pathological apoptosis
Clients: Prescribers
info@bionexis.com
Identity
History
Actualisation / Updating: 12-Mai-2008 |
1999 - IDF
Le Plessis (near Paris)
www.bionisis.com
Contract, Research
Key words: High-throughput, Purification, OPLC technology (Optimum Performance Laminar Chromatography), Sorbent beds
Mission: to provide third parties with proprietary solutions for the separation, purification and analysis of chemical and biochemical mixtures resulting from organic synthesis, natural product extraction and biological fluids
Clients: Pharmaceutical industry, Research labs
webmaster@bionisis.com
Identity
History
Actualisation / Updating: 12-Mai-2008 |
2001 - Alsace
Strasbourg
www.carex.fr
Discovery, Drugs
Key words: Diabetes
Mission: to undertake innovative research of metabolic diseases, such as type 2 diabetes, obesity and dyslipidemia
Clients: Pharmaceutical industry
carex@carex.fr
Identity
History
Actualisation / Updating: 12-Mai-2008 |
2001 - IDF
Paris
www.celogos.fr
Discovery, Drugs
Key words: Muscle regeneration, Cell repair, Technology platform, Rational Cell Design (RCD), Stress urinary incontinence, Anal incontinence, Ocular myopathies
Mission: to develop and produce innovative cell-based technologies in the field of cellular medicine
Clients: Pharmaceutical industry
contact@celogos.fr
Identity
History
Actualisation / Updating: 12-Mai-2008 |
1998 - IDF
Paris
www.cellpep.fr
Delivery, Drugs
Key words: Generics, Value-added, Long acting release, Formulation, Octreotide, Goserelin
Mission: to develop therapeutics in oncology and infectious diseases
Clients: Pharmaceutical industry
jpboulan@cellpep.fr
Identity
History
Actualisation / Updating: 12-Mai-2008 |
1999 - IDF
Paris
www.diatos.com
Delivery, Drugs
Key words: Drug delivery, Peptides, Tumor targeting, Cancer, Chemotherapy, Prodrugs, Liposome, Vectocell, DaunoXome
Mission: to research, develop and market targeted anti-cancer drugs based on drug-delivery improvements
Clients: Prescribers
contact@diatos.com
Identity
History
Actualisation / Updating: 18-Mai-2009 |
1997 - Rhône-Alpes
Villeurbanne
(near Lyon)
www.drugabusesciences.com
Discovery, Drugs
(also, Delivery, Drugs)
Key words: Antagonism, Addiction, Alcoholism, Toxicomany, Cocaine, Opioids, Naltrexone Depot
Mission: to discover, develop and market medications for the treatment of alcohol and substance abuse and dependence
Clients: Prescribers
mdupire@drugabusesciences.com
Identity
History
Actualisation / Updating: 12-Mai-2008 |
2004 - IDF
Paris
www.no-website.net
Design, Therapy
Key words: Cell therapy, Transplantation, Type 1 Diabetis, Insulin
Mission: to generating lines of human pancreatic beta cells immortalized in culture for transplantation therapies
Clients: Research labs
dslagel@esperanteventures.com
Identity
History
Actualisation / Updating: 24-Sep-2008 |
2005 - IDF
Paris
www.fovea-pharma.com
Discovery, Drugs
Key words: Ophthalmology, Allergy conjunctivitis, Mavular edema, Retinitis pigmentosa
Mission: to discover and develop new treatments focused on ocular diseases (dry eye, age-related macular degeneration, retinitis pigmentosa, diabetic retinopathy), with a special focus on retinal pathologies
Clients: Pharmaceutical industry (own development, up to preclinical)
info@fovea-pharma.com
Age:. AGE() . year(s)
Identity
History
Actualisation / Updating: 05-Oct-2009 |
1993 - Rhône-Alpes
Miribel (Ain)
www.genopoietic.fr
Discovery, Drugs
Key words: Autologous vaccine
Mission: to develop autologous chondrocytes for cartilage repair, gene therapy to treat cancer, as well as to treat graft-versus-host disease (innovative anticancer drugs)
Clients: Pharmaceutical industry
info@genopoietic.fr
Identity
History
Actualisation / Updating: 12-Mai-2008 |
1989 - IDF
Paris
www.genset.fr
Discovery, Drugs
Key words: Pharmacogenomics, DNA sequences
Mission: to undertake research programs in the field of genomics, to analyze the regulatory sequences of the human genome and to initiate the construction of a map of single nucleotide polymorphisms as a tool to accelerate the discovery of genes associated with diseases, notably for CNS and metabolism
Clients: Pharmaceutical industry, Research labs
contacts@genset.fr
Identity
History
Actualisation / Updating: 12-Mai-2008 |
1999 - Méditerranée
Marseille
www.hemosystem.com
Discovery, Diagnostics
Key words: Bacteria, Micro-array, ScanSystem
Mission: to develop new diagnostic tools and associated devices to improve safety in blodd transfusion medecine
Clients: Blood transfusion centers, Hospitals
info@hemosystem.com
Identity
History
Actualisation / Updating: 12-Mai-2008 |
1987 - IDF
Paris
www.idm-biotech.com
Discovery, Drugs
Key words: Melanoma, Sarcoma, Infectious diseases, Junovan
Mission: to develop innovative products that activate the immune system to treat cancers
Clients: Prescribers
idm@idm-biotech.com
Identity
History
Actualisation / Updating: 05-Jun-2009 |
2002 - Méditerranée
Bernis
(near Nîmes)
www.ivagen.com
Discovery, Diagnostics
Key words: Immuno-hematology, Medical devices, HIV, H5N1
Mission: to develop, manufacture and distribute reagents to assist third parties in human, veterinary and plant diagnosis, and to discover proprietary immuno-diagnostics
Clients: Research labs
contact@ivagen.com
Identity
History
Actualisation / Updating: 31-Oct-2008 |
1998 - Centre
Clermont-Ferrand
www.meristem-therapeutics.com
Design, Drugs
(also Discovery, Drugs)
Key words: Therapeutic Proteins, Gene technology, Plants, MABs, Manufacturing, Processing, Third Parties, Merispase, Cystic fibrosis
Mission: to produce therapeutic proteins (e.g., monoclonal antibodies) for third parties needs, with many advantages in comparison to other systems (biological safety, high flexibility, low cost), and to develop own portfolio of innovative therapeutic proteins
Clients: Pharmaceutical industry, Biotechs
meristem@meristem-therapeutics.com
Identity
History
Actualisation / Updating: 16-Feb-2009 |
2000 - IDF
Évry
(near Paris)
www.nautilusbiotech.com
Delivery, Drugs
Key words: Therapeutic Proteins, Slow-released HGH, Interferon alpha, Vitatropin, Belerofon
Mission: to develop therapeutic proteins with novel and superior pharmacological profiles compared with established best-in-class protein drugs
Clients: Prescribers
contact@nautilusbiotech.com
Identity
History
Actualisation / Updating: 11-Jan-2009 |
2000 - Alsace
Mulhouse
www.neuro3d.com
Discovery, Drugs
(also, Contract, Research)
Key words: CNS, Psychiatry, Schizophrenia, Ocaperidone
Mission: to develop innovative treatments for psychiatric disorders such as schizophrenia, depression or anxiety
Clients: Prescribers
contact@neuro3d.com
Identity
History
Actualisation / Updating: 12-Mai-2008 |
1998 -
www.neurotech.fr
Discovery, Drugs
Key words: Retinatis, CNTF, Encapsulated Cell Technology
Mission: to develop sight-saving therapeutics for chronic retinal diseases
Clients: Prescribers
t.shepherd@neurotech.fr
Identity
History
Actualisation / Updating: 12-Mai-2008 |
2004 - IDF
Romainville
(near Paris)
www.novexel.com
Discovery, Drugs
Key words: Anti-infectives, Anti-fungals
Mission: to develop novel antibacterials designed to overcome the significant global problem of bacterial resistance
Clients: Prescribers
info@novexel.com
Age:. AGE() . year(s)
Identity
History
Actualisation / Updating: 04-Janv-2010 |
1999 - Rhône-Alpes
Lyon
www.orphan-opi.com
Discovery, Drugs
Key words: Orphan diseases, Hematology, Cancer, Transplants, Kidrolase, Erwinase
Mission: to discover and develop new treatment for orphan diseases
Clients: Pharmaceutical industry
opi@orphan-opi.com
Identity
History
Actualisation / Updating: 12-Mai-2008 |
2005 - IDF
Paris
www.shigamedix.com
Discovery, Immunology
Key words: Antigen vectorization, Vaccines, Cancer, Infectious diseases, STxB Platform
Mission: to develop new vaccines based on antigen vectorization STxB proprietary technology designed to specifically target the dendritic cells
Clients: Prescribers
info@shigamedix.com
Identity
History
Actualisation / Updating: 31-Oct-2008 |
1995 - Méditerranée
Nîmes
www.syntem.com
Discovery, Drugs
(also, Delivery, Drugs)
Key words: CNS, Brain barrier
Mission: to develop new drugs as well as to deliver compounds to the brain or other intracellular targets, based on proprietary Pep:trans and Acti:map technology platforms, in the field of CNS diseases
Clients: Prescribers
syntem@syntem.com
Identity
History
Actualisation / Updating: 12-Mai-2008 |
2001 - IDF
Romainville
(near Paris)
www.theraptosis.com
Discovery, Drugs
Key words: Apoptosis control, Cancer, Neuro-degenerative diseases, CytoTrust, MitoTrust
Mission: to design and develop drugs acting on key apoptosis regulators to fight diseases associated with lack or excess of apoptosis including cancer and neurodegenerative diseases
Clients: Pharmaceutical industry (own development up to clinical trials)
info@theraptosis.com
Age:. AGE() . year(s)
Identity
History
Actualisation / Updating: 13-Nov-2009 |
2002 - Rhône-Alpes
Saint-Priest
(near Lyon)
www.biotransat.com
Design, Drugs
(also Contract, Research)
Key words: Target delivery, Viral vectors, Functional genomics, Plasmid developments, Cellular models, Molecule libraries, RNA interference
Mission: to provide taylored cellular models and gene expression studies in functional genomics for third parties
Clients: Pharmaceutical industry, Biotech, Academic labs
transat@transatbiotechnology.com
Identity
History
Actualisation / Updating: 12-Mai-2008 |
1996 - IDF
Courbevoie (near Paris)
www.valigen.com
Discovery, Drugs
Key words: Genomics, Chimeraplasty
Mission: to research in therapeutic target identification and validation using the tools of functional genomics and gene expression analysis, for treatments of cardio-vascular and metabolic conditions, and some cancers
Clients: Pharmaceutical industry, Agro industry
webmaster@valigen.com
Identity
History
Actualisation / Updating: 12-Mai-2008 |
Actualisation / Updating: Feb 08 2010